Candida albicans triggers NLRP3-mediated pyroptosis in macrophages

Eukaryotic Cell

Volumn 13, Issue 2, 2014, Pages 329-340

  Wellington, Melanie ^a   Koselny, Kristy ^a   Sutterwala, Fayyaz S ^b   Krysan, Damian J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CASPASE INHIBITOR; CIAS1 PROTEIN, MOUSE; FUNGAL PROTEIN; GLYCINE; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CANDIDA ALBICANS; CELL CULTURE; CELL DEATH; DNA REPLICATION; DRUG EFFECT; GENETICS; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY;

ANIMALS; CANDIDA ALBICANS; CARRIER PROTEINS; CASPASE 1; CASPASE INHIBITORS; CELL DEATH; CELLS, CULTURED; DNA REPLICATION; FUNGAL PROTEINS; GLYCINE; INFLAMMASOMES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANS-ACTIVATORS;

EID: 84893354236     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00336-13     Document Type: Article

References (47)

1. Moran GP, Coleman D, Sullivan D. 2012. An introduction to the medically important Candida species, p 11-25. In Calderone R, Clancy CJ (ed), Candida and candidiasis, 2nd ed. ASM Press, Washington, DC.
2. Vazquez JA, Sobel JD. 2003. Candidiasis, p 143-187. In Dismukes WE, Pappas PG, Sobel JD (ed), Clinical mycology. Oxford University Press, Oxford, United Kingdom.
3. Miramon P, Kasper L, Hube B. 2013. Thriving in the host: Candida spp. interaction with phagocytic cells. Med. Microbiol. Immunol. 202:183-195. http://dx.doi.org/10.1007/s00430-013-0288-z.
4. Ngo LY, Karahara S, Kumaska DK, Knoblaugh SE, Jhingran A, Hohl TM. 2014. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J. Infect. Dis. 209:109-119. http: //dx.doi.org/10.1093/infdis/jit413.
5. Lionakis MS, Lim JK, Lee CC, Murphy PM. 2011. Organ specific immune responses in a mouse model of invasive candidiasis. J. Innate Immun. 3:180-199. http://dx.doi.org/10.1159/000321157.
6. Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS. 2009. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J. Immunol. 183:3578-3581. http://dx.doi.org/10.4049 /jimmunol.0901323.
7. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5:487-497. http://dx.doi.org/10.1016/j.chom.2009.05.002.
8. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A, Tschopp J, Ruland J. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459:433-436. http: //dx.doi.org/10.1038/nature07965.
9. Tomalka J, Ganesan S, Azodi E, Patel K, Majmudar P, Hall BA, Fitzgerald KA, Hise AG. 2011. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog. 7:e1002379. http://dx.doi.org/10.1371/journal.ppat.1002379.
10. Franchi L, Munoz-Planillo R, Nunez G. 2012. Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 13:325-332. http: //dx.doi.org/10.1038/ni.2231.
11. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140:821-832. http://dx.doi.org/10.1016/j.cell.2010.01.040.
12. Joly S, Eisenbarth SC, Olivier AK, Williams A, Kaplan DH, Cassel SL, Flavell RA, Sutterwala FS. 2012. Cutting edge: Nlrp10 is essential for protective antifungal adaptive immunity against C. albicans. J. Immunol. 189:4713-4717. http://dx.doi.org/10.4049/jimmunol.1201715.
13. Pedra JHF, Cassel SL, Sutterwala FS. 2009. Sensing pathogens and danger signals by the inflammasome. Curr. Opin. Immunol. 21:10-16. http: //dx.doi.org/10.1016/j.coi.2009.01.006.
14. Jimenez-Lopez C, Lorenz MC. 2013. Fungal immune evasion in a model host-pathogen interaction: Candida albicans versus macrophages. PLoS Pathog. 11:e1003741. http://dx.doi.org/10.1371/journal.ppat.1003741.
15. Wellington M, Koselny K, Krysan DJ. 2012. Candida albicans morphogenesis is not required for macrophage IL-1β production. mBio 4(1): e00433-12. http://dx.doi.org/10.1128/mBio.00433-12.
16. Miao E, Rajan JV, Aderm A. 2011. Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243:206-214. http://dx.doi.org/10.1111/j.1600-065X.2011.01044.x.
17. Chen KW, Schroder K. 2013. Antimicrobial functions of the inflammasomes. Curr. Opin. Microbiol. 16:311-318. http://dx.doi.org/10.1016 /j.mib.2013.02.004.
18. Noble SM, French S, Kohn LA, Chen V, Johnson AD. 2010. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 42:590-598. http: //dx.doi.org/10.1038/ng.605.
19. Bliss JM, Basavegowda KP, Watson WJ, Sheikh AV, Ryan RM. 2008. Vertical and horizontal transmission of Candida albicans in very low weight infants using DNA fingerprinting techniques. Pediatr. Infect. Dis. J. 27:231-235. http://dx.doi.org/10.1097/INF.0b013e31815bb69d.
20. Cormack BP, Falkow S. 1999. Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics 151:979-987.
21. Homann OR, Dea J, Noble SM, Johnson AD. 2009. A phenotypic profile of the Candida albicans regulatory network. PLoS Genet. 5:e1000783. http: //dx.doi.org/10.1371/journal.pgen.1000783.
22. Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, Rogers PD. 2008. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Eukaryot. Cell 7:1180-1190. http://dx.doi.org/10.1128/EC.00103-08.
23. Wellington M, Kolan K, Krysan DJ. 2009. Live Candida albicans suppresses production of reactive oxygen species in phagocytes. Infect. Immun. 77:405-413. http://dx.doi.org/10.1128/IAI.00860-08.
24. Sutterwala FS, Ogura Y, Szcsepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galan JE, Askenase PW, Flavell RA. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity though its regulation of caspase-1. Immunity 24:317-327. http: //dx.doi.org/10.1016/j.immuni.2006.02.004.
25. Lara-Tejero M, Sutterwala FS, Ogura Y, Gran EP, Bertin J, Coyle AJ, Flavell FA, Galan JE. 2006. The role of caspase-1 in Salmonella typhimurium pathogenesis. J. Exp. Med. 203:1407-1412. http://dx.doi.org/10.1084/jem.20060206.
26. Zheng TS, Hunot S, Kuida K, Momoi Srinivasan TA, Nicholson DW, Lazebnik Y, Flavell RA. 2000. Deficiency in caspage-9 or caspase-3 induces compensatory caspase activation. Nat. Med. 6:1241-1247. http://dx.doi.org/10.1038/81343.
27. Fink SL, Cookson BL. 2006. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell. Microbiol. 8:1812-1825. http://dx.doi.org/10.1111/j.1462-5822.2006.00751.x.
28. Bergsbaken T, Cookson BT. 2007. Macrophage activation redirects Yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog. 3:e161. http://dx.doi.org/10.1371/journal.ppat.0030161.
29. Fortier A, Diez E, Gros P. 2005. Naip5/Birc1e and susceptibility to Legionella pneumophila. Trends Microbiol. 13:328-335. http://dx.doi.org /10.1016/j.tim.2005.05.007.
30. Tuite A, Elias M, Picard S, Mullick A, Gros P. 2005. Genetic control of susceptibility to Candida albicans in susceptible A/J. and resistant C57BL/6J mice. Genes Immun. 6:672-682. http://dx.doi.org/10.1038/sj.gene.6364254.
31. Puri AW, Broz P, Shen A, Monack DM, Bogyo M. 2012. Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection. Nat. Chem. Biol. 8:745-747. http://dx.doi.org/10.1038/nchembio.1023.
32. Gow NAR, van de Veerdonk FL, Brown AJP, Netea MG. 2011. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat. Rev. Microbiol. 10:112-122. http://dx.doi.org/10.1038 /nrmicro2711.
33. Garcia-Rodas R, Gonzalez-Camacho F, Rodriguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. 2011. The interaction between Candida krusei and murine macrophages results in multiple outcomes, including intracellular survival and escape from killing. Infect. Immun. 79:2136-2144. http://dx.doi.org/10.1128/IAI.00044-11.
34. Liu H, Styles CA, Fink GR. 1993. Elements of the yeast pheromone response pathway required for filamentous growth of diploids. Science 262:1741-1744. http://dx.doi.org/10.1126/science.8259520.
35. Liu Styles H, Styles CA, Fink GR. 1996. Saccharomyces cerevisiae S288c has a mutation in FL08, a gene required for filamentous growth. Genetics 144:967-978.
36. Ryan O, Shapiro RS, Kurat CF, Mayhew D, Baryshnikova A, Chin B, Lin ZY, Cox MJ, Vizeacoumar F, Cheung D, Bahr S, Tsui K, Tebbji F, Sellam A, Istel F, Schwarzmüller T, Reynolds TB, Kuchler K, Gifford DK, Whiteway M, Giaever G, Nislow C, Costanzo M, Gingras AC, Mitra RD, Andrews B, Fink GR, Cowen LE, Boone C. 2012. Global gene deletion analysis exploring yeast filamentous growth. Science 337:1353-1356. http://dx.doi.org/10.1126/science.1224339.
37. Flowers SA, Barker KS, Berlow EL, Chadwick SG, Gygax SE, Morschhauser J, Rogers PD. 2012. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Eukaryot. Cell 11:1289-1299. http://dx.doi.org /10.1128/EC.00215-12.
38. Gringhuis SI, Kaptein TM, Wevers BA, van der Vlist M, Boekhout T, Feijtenbeek TB. 2012. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat. Immunol. 13:246-254. http://dx.doi.org/10.1038 /ni.2222.
39. van de Veerdonk FL, Joosten LA, Devesa I, Mora-Montes HM, Kanneganti TD, Dinarello CA, van der Meer JW, Gow NAB, Kullberg BJ, Netea MG. 2009. Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans. J. Infect. Dis. 199:1087-1096. http://dx.doi.org/10.1086 /597274.
40. Wheeler RT, Kombe D, Agarwala SD, Fink GR. 2008. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog. 4:e1000227. http://dx.doi.org/10.1371 /journal.ppat.1000227.
41. Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Wooldford CA, Nett JE, Taff H, Norice CT, Andes DR, Lanni F, Mitchell AP. 2012. Portrait of Candida albicans adherence regulators. PLoS Pathog. 8:e1002525. http: //dx.doi.org/10.1371/journal.ppat.1002525.
42. Snodgrass RG, Huang S, Choi I-W, Rutledge JC, Hwang DH. 2013. Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids. J. Immunol. 191:4337-4347. http://dx.doi.org/10.4049/jimmunol.1300298.
43. Youm Y-H, Kanneganti T-D, Bandanmagsar B, Zhu X, Ravussin A, Adijiang A, Owen JS, Thomas MJ, Francis J, Parks JS, Dixit VD. 2012. The NLRP3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep. 1:56-68. http://dx.doi.org/10.1016/j.celrep.2011.11.005.
44. Znaidi S, Weber S, Al-Abdin OZ, Bomme P, Saidane S, Drouin S, Lemieux S, De Deken X, Robert F, Raymond M. 2008. Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot. Cell 7:836-847. http://dx.doi.org/10.1128/EC.00070-08.
45. Lohberger A, Coste AT, Sanglard D. 2014. Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence. Eukaryot. Cell 13:127-142. http://dx.doi.org/10.1128/EC.00245-13.
46. Miao E, Leaf IA, Treuting PM, Mao DP, Dors M, Sakar A, Warren SE, Wewers MD, Aderem A. 2010. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11:1136-1142. http://dx.doi.org/10.1038/ni.1960.
47. Lamkanfi M. 2011. Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 11:213-220. http://dx.doi.org/10.1038/nri2936.